Replies to post #331504 on NorthWest Biotherapeutics Inc (NWBO)

[VikingInvest]

Not sure where you get your information, but RS is only bad if done to remain listed, which is the majority of the times RS is used as a tool In most other situations, it is a positive, as when done in connection with an uplisting. It opens the door to institutional investors, who otherwise would not be able to buy due to their investment strategies. But you are entitled to your opinion

[snoopycomic]

I agree, RS will be useless. Need TLD first.